SPC246

Inótersen og sölt þar af, að meðtöldum natríumsöltum

  • Status:
    Veitt
  • Application date:
    3.1.2019
  • Application published:
    15.1.2019
  • Grant published:
    15.7.2022
  • Max expiry date:
    9.7.2033
  • Medicine name:
    Tegsedi
  • Medicine for children:
    No

Timeline

Today
3.1.2019Application
15.1.2019Publication
15.7.2022Registration
9.7.2033Expires

Marketing license

  • IS authorization number:
    EU/1/18/1296/001-002
  • Date:
    25.7.2018
  • Foreign authorization number:
    EU/1/18/1296
  • Date:
    6.7.2018

Owner

  • Name:
    Ionis Pharmaceuticals, Inc.
  • Address:
    2855 Gazelle Court, Carlsbad, CA US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents